Platelet-Rich Plasma Injection Versus Hydrodissection in the Treatment of Carpal Tunnel Syndrome
Trial Parameters
Brief Summary
The goal of this clinical trial is to compare the efficacy of Ultrasound-Guided Platelet-Rich Plasma Injection versus Hydrodissection (using 2ml saline, 2ml dexamethasone and 1ml lidocaine) in the Treatment of Carpal Tunnel Syndrome. The main questions it aims to answer are: * Which modality is more effective in reducing symptoms and improving function in patients with Carpal tunnel syndrome * Asses safety profile of both methods Participants will: * Randomized to one of the two arms * Visit the clinic 1 and 3 months after intervention * Assessed for efficacy and safety of the intervention
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed clinically as carpal tunnel syndrome with at least 3 months of symptoms and confirmed electro-physiologically as carpal tunnel syndrome Exclusion Criteria: * Onset of carpal tunnel syndrome during pregnancy * Co-existence of brachial plexopathy or thoracic outlet syndrome by clinical examination * Previous carpal tunnel decompressive surgery or corticosteroid injection in carpal tunnel * Patients with infection or local edema at the site of injection.